Drug Trial Radar · NCT05979779
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
Last checked: Nov 19, 2026Latest source record: Apr 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
219
Actual
Start
Sep 5, 2023
Primary completion
Jan 21, 2025
Study completion Jun 2025
Sponsor
- Lead sponsor
- Rivus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 7, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in subjects with nonalcoholic steatohepatitis (NASH). Six months (26 weeks) of dosing is planned, and subjects will be followed for safety, efficacy, pharmacodynamics (PD), and pharmacokinetics (PK) during this time. The end-of-study visit will take place approximately 4 weeks after the last dose of the study drug (Week 30).
Conditions
- Non-Alcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis
- Fatty Liver
Interventions
HU6Drug
HU6 is being evaluated for its efficacy in improving liver fat content in subjects with Nonalcoholic Steatohepatitis (NASH)
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change from baseline in liver fat, as assessed by magnetic resonance imaging liver proton density fat fraction (MRI-Liver PDFF) at 6 months (26 weeks)Time frame: 6 months
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
ProSciento CRU
Chula Vista, California
Velocity Clinical Research
Los Angeles, California
Catalina Research Institute
Montclair, California
Northern California Research Center
Sacramento, California
Metro Clinical Trials
San Bernardino, California
Synergy Healthcare
Bradenton, Florida
ABMED Clinical Research Corp.
Cape Coral, Florida
Southwest General Healthcare Center
Fort Myers, Florida
Miami Clinical Research
Miami, Florida
Advanced Clinical Research
Miami, Florida
Century Research, LLC
Miami, Florida
Entrust Clinical Research
Miami, Florida
Panax Clinical Research
Miami Lakes, Florida
Tandem Clinical Research
Marrero, Louisiana
CenExel HRI
Berlin, New Jersey
Lillestol Research
Fargo, North Dakota
IMA Clinical Research-Austin
Austin, Texas
Mt Olympus Medical Research
Houston, Texas
Houston Research Institute
Houston, Texas
Texas Liver Institute
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.